Cytokinetics, Incorporated

US$53.69As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CYTKHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 18.62%
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.47
PE TTM —
TSR TTM (15.57%)
Mkt cap US$7.479B
ROIC (45.76%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$55
2.41%
(89.45%)
Buy 7|11|1|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.71
0.78
0.86
0.88
11.16%
9.97%
23.28%
25.26%
Revenue$M
599.1
591.7
598.6
606.1
4.99%
3.27%
7.66%
3.50%
Peers (US$7.479B)
Cap (US$)
PE
7.236B
75.71x
Capital
TTM
5Y
10Y
Leveragex
1.248
2.205
1.430
EBIT/Intx
0.551
0.773
0.797
Own earn%
23.39
(11.40)
(19.25)
Sh yield%
25.01
14.89
13.96
Owners
Insiders/Inst%
13.76
87.39
Short interest%
4.36
SBC / revenue%
4.60
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
2–9
$1 testx
−0.2
Incr. ROIC%
3